SABRIL (vigabatrin) is a prescription medicine made use of with other treatments in adults and youngsters 2 years of age and older with refractory complicated partial seizures (CPS) that have actually not reacted all right to a number of other therapies and if the feasible benefits outweigh the threat of vision loss.
It is advised that your healthcare provider examination your (or your child's) vision prior to or within 4 weeks after starting SABRIL and at least every 3 months throughout therapy till SABRIL is stopped. Tell your healthcare provider if you or your youngster have any kind of adverse effects that bothers you or that does not disappear.
Inform your healthcare provider if you are expectant or plan to get expectant. If vision screening can not be done, your doctor might continue suggesting SABRIL, yet will not be able to watch for any kind of vision loss. If vision tests are not done frequently, your healthcare provider may quit recommending SABRIL for you (or your youngster).